SE7612234L - Nya piperidinderivat. - Google Patents

Nya piperidinderivat.

Info

Publication number
SE7612234L
SE7612234L SE7612234A SE7612234A SE7612234L SE 7612234 L SE7612234 L SE 7612234L SE 7612234 A SE7612234 A SE 7612234A SE 7612234 A SE7612234 A SE 7612234A SE 7612234 L SE7612234 L SE 7612234L
Authority
SE
Sweden
Prior art keywords
piperide
individuals
new
propyl
phenoxymethyl
Prior art date
Application number
SE7612234A
Other languages
English (en)
Swedish (sv)
Inventor
W-G Friebe
M Thiel
K Stach
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7612234L publication Critical patent/SE7612234L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7612234A 1975-11-07 1976-11-03 Nya piperidinderivat. SE7612234L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7612234L true SE7612234L (sv) 1977-05-07

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612234A SE7612234L (sv) 1975-11-07 1976-11-03 Nya piperidinderivat.

Country Status (20)

Country Link
US (1) US4243807A (cs)
JP (1) JPS6055509B2 (cs)
AT (1) AT352726B (cs)
BE (1) BE847973A (cs)
CA (1) CA1077942A (cs)
CH (3) CH624102A5 (cs)
DD (1) DD126942A5 (cs)
DE (1) DE2549999A1 (cs)
DK (1) DK494876A (cs)
FI (1) FI763148A7 (cs)
FR (1) FR2330678A1 (cs)
GB (1) GB1502050A (cs)
HU (1) HU171237B (cs)
IE (1) IE43866B1 (cs)
IT (1) IT1063618B (cs)
LU (1) LU76141A1 (cs)
NL (1) NL7612286A (cs)
SE (1) SE7612234L (cs)
SU (3) SU633473A3 (cs)
ZA (1) ZA766381B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
FI934894A0 (fi) * 1991-05-07 1993-11-05 Merck & Co Inc Fibrinogenreceptorantagonister
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2144763A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH08504194A (ja) * 1992-12-01 1996-05-07 メルク エンド カンパニー インコーポレーテッド フィブリノーゲンレセプターアンタゴニスト
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
DE69615063T2 (de) * 1995-09-28 2002-04-25 Kaken Pharmaceutical Co., Ltd. Verfahren zur herstellung von 4-methylen piperidinen
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
ES2434250T3 (es) 2008-07-24 2013-12-16 Theravance, Inc. Compuestos de 3-(fenoxifenilmetil)pirrolidina
RU2515612C2 (ru) 2008-11-14 2014-05-20 Тереванс, Инк. 4-[2-(2-фторфеноксиметил)фенил]пиперидиновые соединения
EP2419405A1 (en) * 2009-04-15 2012-02-22 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
US7994209B2 (en) * 2009-07-13 2011-08-09 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
EP2456436B1 (en) 2009-07-21 2014-06-25 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
WO2011119461A1 (en) * 2010-03-22 2011-09-29 Theravance, Inc. 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
JP5873877B2 (ja) 2010-10-11 2016-03-01 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー セロトニン再取込みインヒビター
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ATA823776A (de) 1979-03-15
IE43866B1 (en) 1981-06-17
ZA766381B (en) 1977-10-26
BE847973A (fr) 1977-05-04
FI763148A7 (cs) 1977-05-08
NL7612286A (nl) 1977-05-10
JPS6055509B2 (ja) 1985-12-05
GB1502050A (en) 1978-02-22
US4243807A (en) 1981-01-06
JPS5259163A (en) 1977-05-16
SU633473A3 (ru) 1978-11-15
DE2549999A1 (de) 1977-05-12
CH627166A5 (cs) 1981-12-31
SU662009A3 (ru) 1979-05-05
SU867298A3 (ru) 1981-09-23
CH625788A5 (cs) 1981-10-15
DD126942A5 (cs) 1977-08-24
FR2330678A1 (fr) 1977-06-03
CH624102A5 (cs) 1981-07-15
HU171237B (hu) 1977-12-28
DK494876A (da) 1977-05-08
IE43866L (en) 1977-05-07
AT352726B (de) 1979-10-10
LU76141A1 (cs) 1977-05-18
DE2549999C2 (cs) 1989-01-26
FR2330678B1 (cs) 1980-11-07
CA1077942A (en) 1980-05-20
IT1063618B (it) 1985-02-11

Similar Documents

Publication Publication Date Title
SE7612234L (sv) Nya piperidinderivat.
ES8406429A1 (es) "un metodo de preparacion de nuevas sulfonamidas sustituidas" nota: se solicita como divisional de la patente de invencion n 516.504.
ES475677A1 (es) Procedimiento para la preparacion de nuevos 4-hidroxi-2h-1,2-benzotiazin-3-carboxamido-1,1-dioxidos.
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
SE7706520L (sv) Guanidinderivat
KR830005148A (ko) 항 알러지성 이미도디설파마이드의 제조방법
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
FR2297615A1 (fr) Nouvelles perhalogenoalcoylamidines substituees comme stimulants cardiaques
ATE93853T1 (de) Substituierte chinolinderivate.
ES459283A1 (es) Procedimiento para preparar 1,1-1-triaril-alquilaminas.
BG34036A3 (bg) Метод за получаване на пропаргил -2- фениламино- имидазолини-(2) и техните присъединителни с киселина соли
ATE799T1 (de) Verfahren zur herstellung von isatosaeureanhydriden.
GB1398993A (en) Triazolyl-styryl compounds
DK121383D0 (da) Fremgangsmade til fremstilling af 8-substituerede pyrrolizidinderivater
ES8105741A1 (es) Un procedimiento para preparar compuestos de tiofosfonato nosimetricos
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG28414A4 (bg) Метод за получаване на 1-хидрокси-тетрахидробензо(с)хинолинони
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
FR2364214A2 (fr) Benzimidazo-(1,2-a)-quinoleines et leur preparation
SE7606063L (sv) Forfarande for framstellning av tienopyridininderivat
ATE2521T1 (de) Verfahren zur herstellung von 2,3-dioxo-1,4benzoxazinderivaten.
ES8601141A1 (es) Un procedimiento para la produccion de derivados de isoquinolina sustituidos
SE7507039L (sv) Nya bensodiazepinderivat jemte sett for deras framstellning.
FR2362191A1 (fr) Colorants naphtolactames

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612234-0

Format of ref document f/p: F